IMDX
Insight Molecular Diagnostics Inc.
4.00$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +36.7% | +49.9% | -3.6% | -37.2% | +12.3% | +967.3% | +24.1% | -67.8% | -6.9% | +40.5% | |
| – | +470.8% | -49.2% | +76.8% | -9.3% | +102.5% | +69.1% | +35.0% | +46.8% | -34.5% | -70.9% | +16.0% | |
| – | -27.9% | +0.5% | -129.4% | – | -256.6% | – | -92.5% | -1,403.4% | – | – | – | |
| – | +5,455.6% | -78.8% | -14.2% | -65.9% | +2,861.3% | +33.7% | +83.1% | +93.1% | -93.5% | +83.6% | +517.2% | |
| – | -76.1% | -157.5% | – | -103.7% | +39,948.4% | -5.4% | +18.8% | -68.9% | -78.5% | -45.1% | +522.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +1,607.1% | -100.0% | – | +382.0% | -100.0% | |
| – | – | – | – | – | – | – | – | -6.8% | -91.8% | +71.8% | +154.7% | |
| – | – | -15.2% | +0.9% | +21.5% | +295.1% | -52.4% | +243.7% | -54.3% | -66.0% | +67.6% | +37.4% | |
| – | +4,860.9% | -71.9% | -218.2% | – | +3,526.3% | -194.9% | – | -149.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.